4.Diabetic Kidney Disease: From Epidemiology to Clinical Perspectives.
Diabetes & Metabolism Journal 2014;38(4):252-260
With worldwide epidemic of diabetes mellitus, diabetic nephropathy which is one of the major causes of microvascular complication has become a serious concern in Korea as well as the rest of the world. In view of its significance, there is an urgent and paramount need for proper managements that could either deter or slow the progression of diabetic nephropathy. Despite advances in care, ever increasing number of patients suffering from diabetic kidney disease and from end-stage renal disease implies that the current management is not adequate in many aspects. The reasons for these inadequacies compromise lack of early diagnosis, failure to intervene with timely and aggressive manner, and lack of understanding on the kind of interventions required. Another issue equally important for the adequate care of patients with diabetic nephropathy is an understanding of past, present and future epidemiology of diabetic nephropathy which serves, especially in Korea, as a material determining standard diagnosis and treatment and a national health-policy decision.
Diabetes Mellitus
;
Diabetic Nephropathies*
;
Diagnosis
;
Early Diagnosis
;
Epidemiology*
;
Humans
;
Kidney Failure, Chronic
;
Korea
;
Renal Insufficiency, Chronic
;
Renal Replacement Therapy
5.Risk Factors and Reversibility of Renal Failure in Patients with Newly Diagnosed Multiple Myeloma.
Hyun Chul WHANG ; Eun Sil KOH ; Jeong Gwan KIM ; Sungjin CHUNG ; Seok Joon SHIN ; Cheol Whee PARK ; Yoon Sik CHANG
Korean Journal of Medicine 2014;86(2):190-197
BACKGROUND/AIMS: Multiple myeloma (MM) is frequently accompanied by renal insufficiency, which has been regarded as a poor prognostic factor for MM. It is known that the incidence and characteristics of MM in Asia differ from those in Western countries. The aim of this study was to evaluate risk factors for renal impairment and to investigate reversible factors for renal failure in patients with MM. METHODS: Patients newly diagnosed with MM from 2005 to 2008 were included. We investigated factors associated with renal insufficiency and those related to recovery from renal dysfunction after 12 weeks of treatment of MM. RESULTS: Renal failure was recognized in 86 (39%) of 221 patients at diagnosis. In the binary logistic regression analysis, low hemoglobin (odds ratio [OR], 0.813; p = 0.02), high beta2microglobulin (OR, 1.006; p < 0.01), and use of angiotensin-converting enzyme inhibitors (ACEi) (OR, 2.783; p < 0.04) at initial presentation were independent risk factors for renal failure in patients with multiple myeloma. After 12 weeks of treatment, 25 of 86 (29%) patients with renal failure had recovered renal function. Good response to chemotherapy (OR, 6.044; p < 0.01) and higher eGFR (OR, 1.084; p < 0.01) were associated with renal function recovery. CONCLUSIONS: Levels of hemoglobin and beta2microglobulin, and use of ACEi were independent risk factors for the development of renal failure in MM patients. The response to chemotherapy and eGFR at diagnosis significantly influenced recovery of renal function.
Angiotensin-Converting Enzyme Inhibitors
;
Asia
;
Diagnosis
;
Drug Therapy
;
Humans
;
Incidence
;
Logistic Models
;
Multiple Myeloma*
;
Recovery of Function
;
Renal Insufficiency*
;
Risk Factors*
6.Risk Factors and Reversibility of Renal Failure in Patients with Newly Diagnosed Multiple Myeloma.
Hyun Chul WHANG ; Eun Sil KOH ; Jeong Gwan KIM ; Sungjin CHUNG ; Seok Joon SHIN ; Cheol Whee PARK ; Yoon Sik CHANG
Korean Journal of Medicine 2014;86(2):190-197
BACKGROUND/AIMS: Multiple myeloma (MM) is frequently accompanied by renal insufficiency, which has been regarded as a poor prognostic factor for MM. It is known that the incidence and characteristics of MM in Asia differ from those in Western countries. The aim of this study was to evaluate risk factors for renal impairment and to investigate reversible factors for renal failure in patients with MM. METHODS: Patients newly diagnosed with MM from 2005 to 2008 were included. We investigated factors associated with renal insufficiency and those related to recovery from renal dysfunction after 12 weeks of treatment of MM. RESULTS: Renal failure was recognized in 86 (39%) of 221 patients at diagnosis. In the binary logistic regression analysis, low hemoglobin (odds ratio [OR], 0.813; p = 0.02), high beta2microglobulin (OR, 1.006; p < 0.01), and use of angiotensin-converting enzyme inhibitors (ACEi) (OR, 2.783; p < 0.04) at initial presentation were independent risk factors for renal failure in patients with multiple myeloma. After 12 weeks of treatment, 25 of 86 (29%) patients with renal failure had recovered renal function. Good response to chemotherapy (OR, 6.044; p < 0.01) and higher eGFR (OR, 1.084; p < 0.01) were associated with renal function recovery. CONCLUSIONS: Levels of hemoglobin and beta2microglobulin, and use of ACEi were independent risk factors for the development of renal failure in MM patients. The response to chemotherapy and eGFR at diagnosis significantly influenced recovery of renal function.
Angiotensin-Converting Enzyme Inhibitors
;
Asia
;
Diagnosis
;
Drug Therapy
;
Humans
;
Incidence
;
Logistic Models
;
Multiple Myeloma*
;
Recovery of Function
;
Renal Insufficiency*
;
Risk Factors*
7.Acute kidney injury in the patient with cancer
Mitchell H ROSNER ; Mark A PERAZELLA
Kidney Research and Clinical Practice 2019;38(3):295-308
Dramatic advances in the care of patients with cancer have led to significant improvement in outcomes and survival. However, renal manifestations of the underlying cancer as well as the effects of anti-neoplastic therapies leave patients with significant morbidity and chronic kidney disease risks. The most common renal manifestations associated with cancer include acute kidney injury (AKI) in the setting of multiple myeloma, tumor lysis syndrome, post-hematopoietic stem cell therapy, and AKI associated with chemotherapy. Knowledge of specific risk factors, modification of risk and careful attention to rapid AKI diagnosis are critical for improving outcomes.
Acute Kidney Injury
;
Diagnosis
;
Drug Therapy
;
Humans
;
Multiple Myeloma
;
Renal Insufficiency, Chronic
;
Risk Factors
;
Stem Cells
;
Tumor Lysis Syndrome
8.Inadvertent haemodialysis in a pulmonary tuberculosis patient with hypercalcaemia.
Chai Soon NGIU ; Chee Yean LOO ; Andrea Y L BAN ;
Annals of the Academy of Medicine, Singapore 2010;39(5):415-416
Cachexia
;
etiology
;
Cough
;
Delayed Diagnosis
;
Fever
;
Humans
;
Hypercalcemia
;
etiology
;
Male
;
Middle Aged
;
Radiography
;
Renal Dialysis
;
Renal Insufficiency
;
etiology
;
therapy
;
Tuberculosis, Pulmonary
;
complications
;
diagnostic imaging
9.Acute kidney injury and continuous renal replacement therapy in children; what pediatricians need to know.
Myung Hyun CHO ; Hee Gyung KANG
Korean Journal of Pediatrics 2018;61(11):339-347
Acute kidney injury (AKI) is characterized by abrupt deterioration of renal function, and its diagnosis relies on creatinine measurements and urine output. AKI is associated with higher morbidity and mortality, and is a risk factor for development of chronic kidney disease. There is no proven medication for AKI. Therefore, prevention and early detection are important. Physicians should be aware of the risk factors for AKI and should monitor renal function in high-risk patients. Management of AKI includes optimization of volume status and renal perfusion, avoidance of nephrotoxic agents, and sufficient nutritional support. Continuous renal replacement therapy is widely available for critically ill children, and this review provides basic information regarding this therapy. Long-term follow-up of patients with AKI for renal function, blood pressure, and proteinuria is recommended.
Acute Kidney Injury*
;
Blood Pressure
;
Child*
;
Creatinine
;
Critical Illness
;
Diagnosis
;
Follow-Up Studies
;
Humans
;
Mortality
;
Nutritional Support
;
Perfusion
;
Proteinuria
;
Renal Insufficiency, Chronic
;
Renal Replacement Therapy*
;
Risk Factors
10.Report of a case with branchio-oto-renal syndrome.
Chinese Journal of Pediatrics 2006;44(9):704-706
Abnormalities, Multiple
;
diagnosis
;
pathology
;
physiopathology
;
Branchio-Oto-Renal Syndrome
;
diagnosis
;
pathology
;
physiopathology
;
therapy
;
Child
;
Deafness
;
etiology
;
physiopathology
;
Diagnosis, Differential
;
Ear
;
abnormalities
;
Female
;
Humans
;
Kidney
;
abnormalities
;
Renal Insufficiency
;
etiology
;
physiopathology
;
therapy